Skip to Main Content

Author Details

Daniela Schilling
Technical University of Munich (TUM)
2005
43
17
PMIDPaper TitleJournal TitlePublished Year
37509330Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases.Cancers (Basel)2023
37627079Establishment of a 3D Model to Characterize the Radioresponse of Patient-Derived Glioblastoma Cells.Cancers (Basel)2023
35348380X-ray Dark-Field CT for Early Detection of Radiation-induced Lung Injury in a Murine Model.Radiology2022
33211140Early detection of radiation-induced lung damage with X-ray dark-field radiography in mice.Eur Radiol2021
33906866The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>.Cancer Immunol Res2021
33705498Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.PLoS One2021
33839203Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer.Radiother Oncol2021
34611553In-vivo X-ray dark-field computed tomography for the detection of radiation-induced lung damage in mice.Phys Imaging Radiat Oncol2021
34830813Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse Model of Human Pancreatic Cancer.Cancers (Basel)2021
34202589Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines.Int J Mol Sci2021
32123256Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines.Sci Rep2020
33317198The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer.Cancers (Basel)2020
31569342Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922.Cells2019
31430337Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.PLoS One2019
31201502Selenium does not affect radiosensitivity of breast cancer cell lines.Radiat Environ Biophys2019
29086374Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells.Methods Mol Biol2018
29882045Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET.J Neurooncol2018
29947818MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model : A treatment planning study.Strahlenther Onkol2018
30463322Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine.Cancers (Basel)2018
30537516Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.Cancer Cell2018
28808749BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model : Experiences with a liquid fiducial marker.Strahlenther Onkol2017
28108313The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition.Cancer Lett2017
27259245A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.Oncotarget2016
26585323The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.Immunogenetics2016
25103413A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.Cell Stress Chaperones2015
25854583NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.Cancer Immunol Immunother2015
25681671The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation.Cancer Lett2015
25721082Sensitizing tumor cells to radiation by targeting the heat shock response.Cancer Lett2015
25760330Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.PLoS Pathog2015
24521683Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models.Int J Radiat Oncol Biol Phys2014
24912482Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck.Radiat Oncol2014
22933182Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levels.Cell Stress Chaperones2013
22347438Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α.PLoS One2012
22687194Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation.Int J Radiat Oncol Biol Phys2012
22318330Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines.Strahlenther Onkol2012
20117293Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck.Int J Radiat Oncol Biol Phys2010
20557857Radiation induced stress proteins.Int J Clin Pharmacol Ther2010
19289606Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells.FASEB J2009
18077030PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck.Radiother Oncol2008
17390074Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.Oncol Rep2007
17663760Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.BMC Cancer2007
17671400Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells.Oncology2006
15799959Differential inhibition of inducible T cell cytokine secretion by potent iron chelators.J Biomol Screen2005
  • 1 - 43 of 43

Recommended Authors

Iris Chiara Salaroglio
University of Turin
Career Start Year 2013
Number of shared co-authors 1
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 0
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 2
Ludwig Dubois
Maastricht University
Career Start Year 2004
Number of shared co-authors 2
Ayman Oweida
Universite de Sherbrooke
Career Start Year 2004
Number of shared co-authors 0
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 3
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 2
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 2
Marianne Koritzinsky
Princess Margaret Cancer Centre University Health Network
Career Start Year 1998
Number of shared co-authors 2
Michael Bergqvist
Umea University
Career Start Year 1998
Number of shared co-authors 0
Marc Vooijs
Maastricht University Medical Centre+
Career Start Year 1997
Number of shared co-authors 1
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Ranjit S Bindra
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Johan Bussink
Radboud University, Nijmegen Medical Centre
Career Start Year 1995
Number of shared co-authors 2
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 3
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 2
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Career Start Year 1993
Number of shared co-authors 3
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 2
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 3
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2
Catharine M L West
University of Manchester
Career Start Year 1981
Number of shared co-authors 2
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 2
Richard P Hill
Princess Margaret Cancer Centre
Career Start Year 1968
Number of shared co-authors 2
J. Martin Brown
Stanford University School of Medicine
Career Start Year 1968
Number of shared co-authors 1

Collaborators

Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers 3
Fred C G J Sweep
Radboud University Medical Centre
Co-authored papers 3
Vladimir Kuryshev
Heidelberg University
Co-authored papers 2
Vyacheslav Amstislavskiy
Max-Planck-Institute for Molecular Genetics
Co-authored papers 1
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers 1
Olga Bogatyrova
German Cancer Research Center
Co-authored papers 1
Clarissa Feuerstein
German Cancer Research Center (DKFZ), Heidelberg University
Co-authored papers 1
Peter Vajkoczy
Charite - Universitatsmedizin Berlin
Co-authored papers 1
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers 1
Gervaise H Henry
UT Southwestern Medical Center
Co-authored papers 1
Nikos Sidiropoulos
Rigshospitalet, University of Copenhagen
Co-authored papers 1
Joachim Weischenfeldt
University of Copenhagen
Co-authored papers 1
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 1
S??ren Matzk
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Rebecca Pulk
Yale School of Medicine
Co-authored papers 1
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 1
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 1
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Francesco Favero
Universita del Piemonte Orientale
Co-authored papers 1
Hartmut Vatter
University Hospital Bonn
Co-authored papers 1
Clarissa Gerh??user
German Cancer Research Center (DKFZ)
Co-authored papers 1
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 1
Eva Reisinger
German Cancer Research Center (DKFZ)
Co-authored papers 1
Doreen Heckmann
University Children's Hospital
Co-authored papers 1
Hans-J??rg Warnatz
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Alicia Malewska
UT Southwestern Medical Center
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Etsehiwot G Girma
Rigshospitalet, University of Copenhagen
Co-authored papers 1
Dmitry A Gordenin
National Institute of Environmental Health Sciences (NIEHS)
Co-authored papers 1
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 1
Release 1.2